The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...